Total Payments
$17,051
2024 Payments
$1,164
Companies
12
Transactions
78
Medicare Patients
574
Medicare Billing
$87,141
Payment Breakdown by Category
Consulting$10,123 (59.4%)
Food & Beverage$4,216 (24.7%)
Travel$2,463 (14.4%)
Other$250.00 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,123 | 5 | 59.4% |
| Food and Beverage | $4,216 | 61 | 24.7% |
| Travel and Lodging | $2,463 | 11 | 14.4% |
| Honoraria | $250.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,241 | 14 | $0 (2024) |
| AbbVie, Inc. | $3,951 | 9 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $2,993 | 5 | $0 (2024) |
| Novocure Inc. | $2,593 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,087 | 13 | $0 (2024) |
| Servier Pharmaceuticals LLC | $529.99 | 4 | $0 (2021) |
| Novocure GmbH | $250.00 | 1 | $0 (2022) |
| Sirtex Medical Inc | $153.49 | 1 | $0 (2019) |
| PFIZER INC. | $150.00 | 1 | $0 (2024) |
| Foundation Medicine, Inc. | $54.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 16 | Novocure Inc. ($456.39) |
| 2023 | $3,216 | 13 | AstraZeneca Pharmaceuticals LP ($2,548) |
| 2022 | $4,065 | 11 | E.R. Squibb & Sons, L.L.C. ($3,530) |
| 2021 | $2,315 | 8 | E.R. Squibb & Sons, L.L.C. ($1,632) |
| 2020 | $982.69 | 8 | Merck Sharp & Dohme Corporation ($982.69) |
| 2019 | $555.53 | 5 | Novocure Inc. ($402.04) |
| 2018 | $481.58 | 5 | Novocure Inc. ($426.68) |
| 2017 | $4,272 | 12 | AbbVie, Inc. ($3,951) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $153.46 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $336.55 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | Cash or cash equivalent | $59.28 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: Oncology | ||||||
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Oncology | ||||||
| 06/02/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $111.47 | General |
| Category: Oncology | ||||||
| 05/13/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $132.68 | General |
| Category: Oncology | ||||||
| 12/20/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: Oncology | ||||||
| 11/18/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $73.19 | General |
| Category: Oncology | ||||||
| 11/17/2023 | Illumina, Inc. | Oncology Testing (Device) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Genetics | ||||||
| 11/10/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Oncology | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,497.50 | General |
| Category: Oncology | ||||||
| 10/11/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Oncology | ||||||
| 08/17/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $146.59 | General |
| Category: Oncology | ||||||
| 06/24/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $88.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 152 | 266 | $65,370 | $21,470 |
| 2022 | 7 | 170 | 295 | $82,300 | $26,613 |
| 2021 | 5 | 138 | 238 | $63,510 | $22,775 |
| 2020 | 4 | 114 | 215 | $56,627 | $16,282 |
Total Patients
574
Total Services
1,014
Medicare Billing
$87,141
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 57 | 151 | $32,420 | $10,850 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 32 | $9,760 | $3,412 | 35.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $8,928 | $2,308 | 25.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 22 | $4,994 | $2,020 | 40.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $5,487 | $1,606 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $1,727 | $671.22 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 14 | $2,053 | $603.49 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 110 | $33,550 | $11,954 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 57 | 111 | $24,975 | $8,015 | 32.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $5,059 | $1,675 | 33.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 21 | $4,767 | $1,659 | 34.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $4,836 | $1,350 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $6,818 | $1,290 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 15 | $2,295 | $671.62 | 29.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 47 | 112 | $34,160 | $12,728 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 46 | 71 | $15,975 | $5,459 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,137 | $1,695 | 33.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 19 | $4,313 | $1,511 | 35.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 25 | $3,925 | $1,383 | 35.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 47 | 132 | $40,260 | $11,616 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 39 | 50 | $11,250 | $3,051 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 17 | $2,669 | $965.75 | 36.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 15 | 16 | $2,448 | $649.10 | 26.5% |
About John Villano
John Villano is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154434645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Villano has received a total of $17,051 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 78 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($10,123).
As a Medicare-enrolled provider, Villano has provided services to 574 Medicare beneficiaries, totaling 1,014 services with total Medicare billing of $87,141. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Lexington, KY
- Active Since 08/17/2006
- Last Updated 12/01/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1154434645
Products in Payments
- OPDIVO (Biological) $3,581
- IMFINZI (Biological) $2,993
- Optune (Device) $1,731
- KEYTRUDA (Biological) $1,087
- Oncology (Device) $828.72
- SIR-Spheres Microspheres (Device) $153.49
- LORBRENA (Drug) $150.00
- FOUNDATIONONE (Device) $54.90
- OPDUALAG (Drug) $27.73
- Oncology Testing (Device) $24.77
- LIBTAYO (Biological) $22.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781
Reinhold Munker
Hematology & Oncology — Payments: $9,229
Hematology & Oncology $9,229